Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is headquartered in Lewisville, Texas.
| Revenue (TTM) | $825.37M |
| Gross Profit (TTM) | $586.10M |
| EBITDA | $17.00M |
| Operating Margin | -6.75% |
| Return on Equity | -13.40% |
| Return on Assets | -3.25% |
| Revenue/Share (TTM) | $20.68 |
| Book Value | $10.78 |
| Price-to-Book | 1.00 |
| Price-to-Sales (TTM) | 0.53 |
| EV/Revenue | 0.698 |
| EV/EBITDA | 27.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1.60% |
| Shares Outstanding | $40.42M |
| Float | $39.83M |
| % Insiders | 1.86% |
| % Institutions | 90.92% |
Volatility is currently expanding